ERBB2 and Huntington disease: In the Huntington's disease, parkingson's disease, oxidative phosphorylation, and alzheimer's disease pathways, CLTC is involved in inflammatory myofibroblastic tumors [38] and lower expression of MAPT is associated with HER2 overexpression [39].